Status:
COMPLETED
Comparison Between Initial Routine PICC and General IV Access in Terminally Ill Cancer Patients
Lead Sponsor:
Pusan National University Yangsan Hospital
Conditions:
Peripherally Inserted Central Catheter
Intravenous Access
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To establish the IV access strategy for terminally ill cancer patients, using comparisons of the safety, efficacy, and patient-perceived satisfaction between the initially routine PICC insertion group...
Detailed Description
Reliable intravenous (IV) access is an important issue in terminally ill cancer patients, however, they have limited or no peripheral venous access due to edema or long period of IV therapy. Thus, int...
Eligibility Criteria
Inclusion
- Cancer patients with histologically or cytologically confirmed malignancy and fulfilled all of the following conditions
- Patients with expected survival time of 3 months or less due to a progressive disease without additional anticancer treatment. (However, palliative radiation treatment for symptom control is allowed.)
- Patients who need the IV access route continuously for hydration or medication.
- Age18 or older
- Signed and dated informed consent of document indicating that the patient (or legally acceptable representative) has been informed about all pertinent aspects of the trial prior to enrollment
Exclusion
- Patients who showed severe coagulopathy such as thrombocytopenia (Platelet count ≤ 20,000/mm2) or international normalized ratio (INR) prolongation (≥2.0 ) in spite of treatment
- Patients who have an evidence of current sepsis (bacteremia or fungemia)
- 'current' means bacteremia/fungemia without eradication on follow-up peripheral blood culture
- patients with persistent fever (bacteremia or fungemia cannot be ruled out)
- Patients who is impracticable to PICC insertion due to uncontrolled behavioral disorders
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03299868
Start Date
May 1 2017
End Date
June 30 2020
Last Update
August 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea, 50612